Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyglucosamine L112 vs orlistat 60 mg in overweight or obese patients
DRKS00000342Phase 3Completed
- Sponsor
- Certmedica International
- Start
- Feb 2010
- Modality
- Small Molecules, Microbiome Therapeutics, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obesity and Overweight comparing Polyglucosamine L112 with Orlistat 60 mg (2 arms). Started Feb 2010; status: completed.
02
Drugs
polyglucosamine l112orlistat
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on DRKS00000342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000342.